Nanopath Raises $25M for Diagnostics

Cambridge, MA-based Nanopath raised $25M in Series B funding, including $2M in non-dilutive grants. The round was co-led by Norwest and SV Health Investors' MedTech Convergence Fund. Funds will support the commercial launch of its 15-minute vaginitis assay and FDA 510(k) study.